Periwinkle Technologies
PrivateLast Round
Grant
Jan 14, 2025
Total Funding Raised
$1.01M
Company Overview
Periwinkle Technologies operates in Healthcare & Life Sciences and is based in Pune. Its latest recorded funding round was a Grant round in January 2025.
Periwinkle Technologies is a healthtech company that develops AI-enabled portable devices for the detection of cervical abnormalities.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Medical Imaging, Telemedicine
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Periwinkle Technologies Comparables
Compare Periwinkle Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Liger Medical | 89% | |
| Aindra Systems | 88% | |
| AIDOT Inc. | 87% |
For institutional investors. Book with your work email.
Periwinkle Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 14, 2025 | ||||
| Grant | Sep 23, 2020 | ||||
| Grant | Feb 25, 2019 | ||||
| Grant | Dec 13, 2017 |
For institutional investors. Book with your work email.
Periwinkle Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant |
| Department of Science & Technology | Grant |
| Startup India | Grant |
| Zayed Sustainability Prize | Grant |
| Social Alpha | Grant |
| Zone Startups India | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors grew 69% MoM.
- Apr 2, 2025
Monthly visitors grew 1603% MoM, reaching 7.1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 21, 2026
Periwinkle Technologies Pvt. Ltd. showcases its flagship Smart Scope(R) CX, an AI-enabled cervical cancer screening and triage technology, at the BRICS Bharat Innovates Exposition in India on Sep 21st '26.
For institutional investors. Book with your work email.
Periwinkle Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Periwinkle Technologies's valuation, stock price, and market status.
Is Periwinkle Technologies a public or private company?
Periwinkle Technologies is a private company.
What is the current stock price of Periwinkle Technologies?
Periwinkle Technologies is a private company, so its shares have no public market price. Caplight tracks Periwinkle Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Periwinkle Technologies worth (valuation)?
Valuation information for Periwinkle Technologies is not publicly available.
Can I buy Periwinkle Technologies stock?
Periwinkle Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Periwinkle Technologies's last funding round?
Periwinkle Technologies's most recent funding round was Grant on January 14, 2025.
Who are the main investors in Periwinkle Technologies?
Key investors in Periwinkle Technologies include Biotechnology Industry Research Assistance Council, Department of Science & Technology, Startup India, Zayed Sustainability Prize, Social Alpha.
Will Periwinkle Technologies IPO soon?
No public IPO plans have been announced for Periwinkle Technologies.
How can I track Periwinkle Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Periwinkle Technologies's shares on secondary markets.